Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes.

Oncotarget - 17 Nov 2015

Liang Lisa, Aiken Christopher, McClelland Robyn, Morrison Ludivine Coudière, Tatari Nazanin, Remke Marc, Ramaswamy Vijay, Issaivanan Magimairajan, Ryken Timothy, Del Bigio Marc R, Taylor Michael D, Werbowetski-Ogilvie Tamra E

Abstract excerpt

Major research efforts have focused on defining cell surface marker profiles for characterization and selection of brain tumor stem/progenitor cells. Medulloblastoma is the most common primary malignant pediatric brain cancer and consists of 4 molecular subgroups: WNT, SHH, Group 3 and Group 4. Given the heterogeneity within and between medulloblastoma variants, surface marker profiles may be subtype-specific....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Flow Cytometry

Share to EGFR gene

Share to SHH gene

Share to VCAM1 gene

Share to Medulloblastoma

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 26497209
DOI: 10.18632/oncotarget.6195
PMCID: PMC4770744

Genes

SHH
NGFR
EGFR
VCAM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes.PMID 26497209Read ↗

Deconstruction of medulloblastoma cellular heterogeneity reveals differences between the most highly invasive and self-renewing phenotypes.Semantic proximity Read ↗

Medulloblastoma in the age of molecular subgroups: a reviewSemantic proximity Read ↗

Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in MedulloblastomaSemantic proximity Read ↗

Adult Medulloblastoma Comprises Three Major Molecular VariantsSemantic proximity Read ↗

Medulloblastoma in the Molecular EraSemantic proximity Read ↗

Molecular subgroups of medulloblastoma: the current consensusSemantic proximity Read ↗

Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometrySemantic proximity Read ↗

Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a TimeSemantic proximity Read ↗

Roles and interactions of tumor microenvironment components in medulloblastoma with implications for novel therapeuticsSemantic proximity Read ↗

Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical PracticeSemantic proximity Read ↗

Transcriptomic Crosstalk between Gliomas and Telencephalic Neural Stem and Progenitor Cells for Defining Heterogeneity and Targeted Signaling Pathways.Semantic proximity Read ↗

Clinical and Molecular Features in Medulloblastomas Subtypes in Children in a Cohort in TaiwanSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.